Search Results

There are 30786 results for: content related to: Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity

  1. You have free access to this content
    Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis

    International Journal of Cancer

    Volume 137, Issue 8, 15 October 2015, Pages: 2029–2039, Xiaoqian Yang, Jacson Shen, Yan Gao, Yong Feng, Yichun Guan, Zhan Zhang, Henry Mankin, Francis J. Hornicek and Zhenfeng Duan

    Version of Record online : 5 MAY 2015, DOI: 10.1002/ijc.29574

  2. You have free access to this content
    P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2439–2447, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen and Alfred H. Schinkel

    Version of Record online : 14 NOV 2012, DOI: 10.1002/ijc.27912

  3. You have free access to this content
    Local delivery of paclitaxel in the treatment of peripheral arterial disease

    European Journal of Clinical Investigation

    Volume 45, Issue 3, March 2015, Pages: 333–345, Vivian G. Ng, Carlos Mena, Cody Pietras and Alexandra J. Lansky

    Version of Record online : 14 FEB 2015, DOI: 10.1111/eci.12407

  4. Liquid–liquid extraction for recovery of paclitaxel from plant cell culture: Solvent evaluation and use of extractants for partitioning and selectivity

    Biotechnology Progress

    Volume 28, Issue 4, July/August 2012, Pages: 990–997, Timothy J. McPartland, Rohan A. Patil, Michael F. Malone and Susan C. Roberts

    Version of Record online : 18 JUN 2012, DOI: 10.1002/btpr.1562

  5. You have full text access to this Open Access content
    Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen

    Cancer Science

    Volume 103, Issue 4, April 2012, Pages: 821–827, Mingli Xu, Masakatsu Takanashi, Kosuke Oikawa, Hirotaka Nishi, Keiichi Isaka, Takayuki Yoshimoto, Junko Ohyashiki and Masahiko Kuroda

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1349-7006.2012.02221.x

  6. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3748–3761, Firat Yerlikaya, Aysegul Ozgen, Imran Vural, Olgun Guven, Ergun Karaagaoglu, Mansoor A. Khan and Yilmaz Capan

    Version of Record online : 5 AUG 2013, DOI: 10.1002/jps.23686

  7. Self-Assembled Poly(butadiene)-b-poly(ethylene oxide) Polymersomes as Paclitaxel Carriers

    Biotechnology Progress

    Volume 23, Issue 1, 2007, Pages: 278–285, Shuliang Li, Belinda Byrne, JoEllen Welsh and Andre F. Palmer

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp060208

  8. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 4, April 2011, Pages: 1444–1455, Jaclyn M. Hosmer, Soo H. Shin, Adwoa Nornoo, Haian Zheng and Luciana B. Lopes

    Version of Record online : 18 OCT 2010, DOI: 10.1002/jps.22370

  9. Paclitaxel (Taxol)

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 1, January-February 1994, Pages: 3–34, David R. Kohler and Barry R. Goldspiel

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02785.x

  10. Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel

    European Journal of Pain

    Volume 19, Issue 7, August 2015, Pages: 889–898, Z. Wu, S. Wang, I. Wu, M. Mata and D.J. Fink

    Version of Record online : 12 NOV 2014, DOI: 10.1002/ejp.613

  11. Paclitaxel-Loaded Stabilizer-Free Poly(D,L-lactide-co-glycolide) Nanoparticles Conjugated with Quantum Dots for Reversion of Anti-Cancer Drug Resistance and Cancer Cellular Imaging

    Journal of the Chinese Chemical Society

    Volume 56, Issue 5, October 2009, Pages: 923–934, Wen-Shuo Kuo, Yu-Cian Ku, Hei-Tin Sei, Fong-Yu Cheng and Chen-Sheng Yeh

    Version of Record online : 25 SEP 2013, DOI: 10.1002/jccs.200900136

  12. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 6, June 2012, Pages: 775–782, Xiangrui Liu, Jiabei Sun, Xiaomei Chen, Shanshan Wang, Hannah Scott, Xuan Zhang and Qiang Zhang

    Version of Record online : 27 FEB 2012, DOI: 10.1111/j.2042-7158.2012.01471.x

  13. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer

    The Prostate

    Volume 70, Issue 1, 1 January 2010, Pages: 48–60, YouQiang Li, Atsushi Mizokami, Kouji Izumi, Kazutaka Narimoto, Takashi Shima, Jian Zhang, Jinlu Dai, Evan T. Keller and Mikio Namiki

    Version of Record online : 1 SEP 2009, DOI: 10.1002/pros.21037

  14. Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 2, August 2006, Pages: 179–191, Yukiko Nakajima, Takashi Yoshitani, Hiromi Fukushima-Uesaka, Yoshiro Saito, Nahoko Kaniwa, Kouichi Kurose, Shogo Ozawa, Nobuo Aoyagi, Naoyuki Kamatani, Noboru Yamamoto, Hideo Kunitoh, Yuichiro Ohe, Tomohide Tamura, Teruhiko Yoshida, Hironobu Minami, Nagahiro Saijo, Noriko Katori and Jun-ichi Sawada

    Version of Record online : 19 AUG 2006, DOI: 10.1016/j.clpt.2006.04.012

  15. Inhibition of nuclear factor-κB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1777–1782, G.H. LIU, S.R. WANG, B. WANG and B.H. KONG

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00652.x

  16. Flow Cytometric Identification of Paclitaxel-Accumulating Subpopulations

    Biotechnology Progress

    Volume 21, Issue 3, 2005, Pages: 978–983, Michael C. Naill and Susan C. Roberts

    Version of Record online : 5 SEP 2008, DOI: 10.1021/bp049544l

  17. You have free access to this content
    Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy


    Volume 118, Issue 20, 15 October 2012, Pages: 5171–5178, Brandi N. Reeves, Shaker R. Dakhil, Jeff A. Sloan, Sherry L. Wolf, Kelli N. Burger, Arif Kamal, Nguyet A. Le-Lindqwister, Gamini S. Soori, Anthony J. Jaslowski, Joseph Kelaghan, Paul J. Novotny, Daniel H. Lachance and Charles L. Loprinzi

    Version of Record online : 13 MAR 2012, DOI: 10.1002/cncr.27489

  18. Clinical Overview of the Taxanes

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 5P2, September-October 1997, Pages: 110S–125S, Barry R. Goldspiel

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03813.x

  19. You have free access to this content
    Paclitaxel-induced cell death


    Volume 88, Issue 11, 1 June 2000, Pages: 2619–2628, Tzu-Hao Wang, Hsin-Shih Wang and Yung-Kwei Soong

    Version of Record online : 20 NOV 2000, DOI: 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J

  20. CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction

    The Journal of Pathology

    Volume 226, Issue 3, February 2012, Pages: 482–494, Alvin J. X. Lee, Rebecca Roylance, Jil Sander, Patricia Gorman, David Endesfelder, Maik Kschischo, Neil P. Jones, Philip East, Barbara Nicke, Stefka Spassieva, Lina M. Obeid, Nicolai Juul Birkbak, Zoltan Szallasi, Nicole C. McKnight, Andrew J. Rowan, Valerie Speirs, Andrew M. Hanby, Julian Downward, Sharon A. Tooze and Charles Swanton

    Version of Record online : 19 OCT 2011, DOI: 10.1002/path.2998